Literature DB >> 15315850

Tetanus and diphtheria antibodies and response to a booster dose in Brazilian HIV-1-infected women.

Tatiana C S Bonetti1, Regina C M Succi, Lily Y Weckx, L Tavares-Lopes, M Isabel de Moraes-Pinto.   

Abstract

Tetanus and diphtheria (Td) antibodies were studied in HIV-1-infected women during puerperium. HIV group (n=61) was compared with Control group (n=101). Twenty-one women from HIV and 13 from Control group who had antibody levels lower than 0.1 IU/mL received a booster with Td vaccine. Antibodies were assessed by double antigen ELISA. Mean tetanus and diphtheria antibody levels from HIV group were lower than those from Control group. Multiple linear regression analysis showed that tetanus and diphtheria antibody levels were decreased by HIV-1-infection, and that was independent of the reduction due to the time interval between last booster and antibody assessment. After a booster dose, both groups had an increase in mean tetanus and diphtheria antibody levels, but in Control group the levels were higher than in HIV group.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15315850     DOI: 10.1016/j.vaccine.2004.03.023

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Technical and diagnostic performance of five commercial anti-diphtheria toxoid IgG enzyme-linked immunosorbent assay kits.

Authors:  A Faruq; L Dadson; H Cox; F Alcock; A R Parker
Journal:  Clin Vaccine Immunol       Date:  2010-08-25

2.  Determination of tetanus antibodies by a double-antigen enzyme-linked immunosorbent assay in individuals of various age groups.

Authors:  K Caglar; R Karakus; C Aybay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

3.  The seroepidemiology of tetanus in Catalonia, Spain.

Authors:  A Domínguez; P Plans; J Costa; J Espuñes; N Cardeñosa; L Salleras; A Plasència
Journal:  Med Microbiol Immunol       Date:  2007-01-23       Impact factor: 3.402

Review 4.  Immunization of HIV-infected adult patients - French recommendations.

Authors:  Anne Frésard; Amandine Gagneux-Brunon; Frédéric Lucht; Elisabeth Botelho-Nevers; Odile Launay
Journal:  Hum Vaccin Immunother       Date:  2016-07-13       Impact factor: 3.452

Review 5.  Maternal and neonatal tetanus.

Authors:  C Louise Thwaites; Nicholas J Beeching; Charles R Newton
Journal:  Lancet       Date:  2014-08-19       Impact factor: 79.321

Review 6.  An overview of vaccinations in HIV.

Authors:  Edgar Turner Overton
Journal:  Curr HIV/AIDS Rep       Date:  2007-08       Impact factor: 5.495

7.  Neonatal Tetanus Immunity in Nigeria: The Effect of HIV Infection on Serum Levels and Transplacental Transfer of Antibodies.

Authors:  Muhammad Faruk Bashir; Hassan Abdullahi Elechi; Mohammed Garba Ashir; Adamu Ibrahim Rabasa; David Nadeba Bukbuk; Ahmadu Baba Usman; Modu Gofama Mustapha; Mohammad Arab Alhaji
Journal:  J Trop Med       Date:  2016-01-20

8.  Vaccination in patients with HIV infection.

Authors:  Todd D Gleeson; Mark R Wallace; Sybil A Tasker
Journal:  Curr Infect Dis Rep       Date:  2006-03       Impact factor: 3.663

Review 9.  Eradication of tetanus.

Authors:  C L Thwaites; H T Loan
Journal:  Br Med Bull       Date:  2015-11-22       Impact factor: 4.291

10.  Prognosis of neonatal tetanus in the modern management era: an observational study in 107 Vietnamese infants.

Authors:  Phung Khanh Lam; Huynh T Trieu; Inke Nadia D Lubis; Huynh T Loan; Tran Thi Diem Thuy; Bridget Wills; Christopher M Parry; Nicholas P J Day; Phan T Qui; Lam Minh Yen; C Louise Thwaites
Journal:  Int J Infect Dis       Date:  2014-12-12       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.